PetIQ Inc (NASDAQ:PETQ)
| 41.59 BATS BZX Real-Time Price As of 3:12pm ET |  +2.45 / +6.26%Today’s Change | 21.57 Today|||52-Week Range 42.07 | +8.17% Year-to-Date |
Latest PETQ News | Press Releases
| PetIQ (PETQ) Surges 5.8%: Is This an Indication of Further Gains? 8:10am / Zacks.com - Paid Partner Content | PetIQ Stock Shows Every Sign Of Being Modestly Overvalued Apr 19 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 39.14 |
| Today’s open | 39.50 |
| Day’s range | 39.27 - 42.07 |
| Volume | 28,666 |
| Average volume (3 months) | 296,586 |
| Market cap | $1.1B |
Data as of 3:12pm ET, 04/20/2021
Growth & Valuation
| Earnings growth (last year) | -522.15% |
| Earnings growth (this year) | +104.14% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +9.95% |
| P/E ratio | NM |
| Price/Sales | 1.21 |
| Price/Book | 3.63 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AFMDAffimed NV | -0.80 | -8.32% |
| OMEROmeros Corp | +0.49 | +2.71% |
| YMABY-mAbs Therapeutics ... | +0.41 | +1.61% |
| OCULOcular Therapeutix I... | -0.40 | -2.63% |
Data as of 3:12pm ET, 04/20/2021
Financials
| Next reporting date | May 13, 2021 |
| EPS forecast (this quarter) | $0.14 |
| Annual revenue (last year) | $780.1M |
| Annual profit (last year) | -$77.5M |
| Net profit margin | -9.93% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Eagle, Idaho |
Forecasts
